Novavax (NVAX) EBITDA Margin (2010 - 2026)
Novavax (NVAX) posted EBITDA Margin of -91.45% for Q2 2026, down 136.86 percentage points from 45.41% a year earlier and down 82.58 percentage points from the prior quarter.
Powered by 
Analysis
Novavax (NVAX) EBITDA Margin (2010 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, EBITDA Margin at Novavax was -52.27%, down 88.67 percentage points year-over-year; for FY2025, it was 42.76%, up 72.14 percentage points from FY2024.
- Annual EBITDA Margin shows a five-year change of +129.35 percentage points (FY2020 to FY2025).
- In prior years, Novavax's EBITDA Margin was -29.38% in FY2024 (+24.02 pp), -53.40% in FY2023 (-22.33 pp), -31.07% in FY2022 (+114.96 pp) and -146.03% in FY2021 (-59.44 pp).
- Quarterly EBITDA Margin has run from a low of -375.20% in Q1 2023 to a high of 78.58% in Q1 2025 over five years.
- On a year-over-year basis, EBITDA Margin increased in three of the last eight quarters, with an average year-over-year change of -13.77 percentage points.
- The strongest year-over-year quarter for EBITDA Margin in the past five years was Q4 2022, with a gain of 303.41 percentage points; the weakest was Q1 2023, with a drop of 405.89 percentage points.
- According to Business Quant data, EBITDA Margin for the three prior quarters was -8.87% (Q1 2026), 13.15% (Q4 2025) and -243.36% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 39.10% |
| 10 | Novavax | 1.78 Bn | -1.23 Bn | 42.45 Mn | -91.45% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -91.45% |
| Mar 31, 2026 | -8.87% |
| Dec 31, 2025 | 13.15% |
| Sep 30, 2025 | -243.36% |
| Jun 30, 2025 | 45.41% |
| Mar 31, 2025 | 78.58% |
| Dec 31, 2024 | -134.26% |
| Sep 30, 2024 | -143.55% |
| Jun 30, 2024 | 41.43% |
| Mar 31, 2024 | -141.37% |
| Dec 31, 2023 | -59.30% |
| Sep 30, 2023 | -61.13% |
| Jun 30, 2023 | 15.44% |
| Mar 31, 2023 | -375.20% |
| Dec 31, 2022 | -66.22% |
| Sep 30, 2022 | -16.18% |
| Jun 30, 2022 | -256.15% |
| Mar 31, 2022 | 30.69% |
| Dec 31, 2021 | -369.62% |
| Sep 30, 2021 | -169.36% |
API Access
Novavax EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "NVAX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=NVAX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();